Interpretation of AMSTAR 2: a critical appraisal tool for systematic reviews that include randomized or non-randomized studies of healthcare interventions_Chinese Journal of Evidence-Based Medicine

Authors：

TAO Huan ¹ , YANG Letian ² , PING An ² , QUAN Liuliu ² , YANG Xin ² , ZHANG Yonggang ³ , KANG Deying ¹ , LI Jing ¹ , DU Liang ³ , SUN Xin ¹ ,  CHEN Jin ¹

1. Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
2. West China School of Medicine, Sichuan University, Chengdu, 610041, P.R.China;
3. West China Medical Publishers, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;

Corresponding author：

CHEN Jin, Email: ebm_chenjin@126.com

Keywords：

AMSTAR 2; Systematic reviews; Appraisal tool; Interpretation

DOI：

10.7507/1672-2531.201711005

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

The AMSTAR 2, a critical appraisal tool, was developed for assessing systematic reviews which included randomized or non-randomized studies of healthcare interventions, or both. It was recently published in BMJ. This paper introduces AMSTAR 2 and interprets its usage by a published systematic review.

Citation： TAO Huan, YANG Letian, PING An, QUAN Liuliu, YANG Xin, ZHANG Yonggang, KANG Deying, LI Jing, DU Liang, SUN Xin, CHEN Jin. Interpretation of AMSTAR 2: a critical appraisal tool for systematic reviews that include randomized or non-randomized studies of healthcare interventions. Chinese Journal of Evidence-Based Medicine, 2018, 18(1): 101-108. doi: 10.7507/1672-2531.201711005 Copy

1.	Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 2000, 283(15): 2008-2012.
2.	David M, Alessandro L, Jennifer T, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLos Med, 2009, 6(7): e1000097.
3.	Shea BJ, Hamel C, Wells GA, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol, 2009, 62(10): 1013-1020.
4.	Beverley JS, Barnaby CR, George W, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 2017, 358: j4008.
5.	Sterne JA, Hernan MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ, 2016, 355: i4919.
6.	杨丽, 马彩玲, 赵骏达, 等. 腹腔镜与开腹手术治疗早期宫颈癌疗效与安全性的 Meta 分析. 中国循证医学杂志, 2016, 16(2): 200-211.
7.	Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med, 2015, 8(1): 2-10.
8.	马捷, 刘莹, 钟来平, 等. Jadad 量表与 Cochrane 偏倚风险评估工具在随机对照试验质量评价中的应用与比较. 中国口腔颌面外科杂志, 2012, 10(5): 417-422.

1. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 2000, 283(15): 2008-2012.
2. David M, Alessandro L, Jennifer T, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLos Med, 2009, 6(7): e1000097.
3. Shea BJ, Hamel C, Wells GA, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol, 2009, 62(10): 1013-1020.
4. Beverley JS, Barnaby CR, George W, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 2017, 358: j4008.
5. Sterne JA, Hernan MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ, 2016, 355: i4919.
6. 杨丽, 马彩玲, 赵骏达, 等. 腹腔镜与开腹手术治疗早期宫颈癌疗效与安全性的 Meta 分析. 中国循证医学杂志, 2016, 16(2): 200-211.
7. Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med, 2015, 8(1): 2-10.
8. 马捷, 刘莹, 钟来平, 等. Jadad 量表与 Cochrane 偏倚风险评估工具在随机对照试验质量评价中的应用与比较. 中国口腔颌面外科杂志, 2012, 10(5): 417-422.

Previous Article
Yearly-end Thanks and Prospects
Next Article
Introduction of ADOLOPMENT: a GRADE guidelines development tool

Chinese Journal of Evidence-Based Medicine

Interpretation of AMSTAR 2: a critical appraisal tool for systematic reviews that include randomized or non-randomized studies of healthcare interventions

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content